Soluble Tumor Necrosis Factor (TNF) Receptors Conserve TNF Bioactivity in Meningitis Patient Spinal Fluid

The content of tumor necrosis factor (TNF)-α antigen and the bioactivity of soluble TNF receptor type II (sTNF-RII) in cerebrospinal fluid (CSF) from 29 patients with meningeal symptoms and fever were examined. Immunoreactive TNF was demonstrated in CSF from 4 of 7 patients with bacterial meningitis...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases Vol. 174; no. 3; pp. 557 - 563
Main Authors: Moller, Bjarne, Ellermann-Eriksen, Svend, Storgaard, Merete, Obel, Niels, Bendtzen, Klaus, Petersen, Claus Munck
Format: Journal Article
Language:English
Published: Chicago, IL The University of Chicago Press 01-09-1996
University of Chicago Press
Oxford University Press
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The content of tumor necrosis factor (TNF)-α antigen and the bioactivity of soluble TNF receptor type II (sTNF-RII) in cerebrospinal fluid (CSF) from 29 patients with meningeal symptoms and fever were examined. Immunoreactive TNF was demonstrated in CSF from 4 of 7 patients with bacterial meningitis. In 3 of 8 patients with aseptic meningitis, CSF also contained TNF, but TNF bioactivity was confined to samples from patients with bacterial meningitis. Bioactive TNF was exclusively in high-performance liquid chromatography fractions containing 30- to 60-kDa proteins. Lipopolysaccharide induced down-regulation, possibly after shedding of granulocyte surface membrane TNF-RII. Consistently, there was a statistically significant correlation between sTNF-RII and CSF leukocyte counts. Bioactive TNF was found only in CSF containing > 1 ng of sTNF-RII/mL; samples without TNF bioactivity contained less sTNF-RII. Thus, a stabilizing effect of sTNF-RII on the oligomeric cytokine in vivo is plausible.
Bibliography:ark:/67375/HXZ-QJD6L3MF-C
istex:B10966F05AE9E702C5E33F2EF9F650EBC733506E
Reprints or correspondence: Dr. Bjarne Meller, Dept. of Clinical Immunology, University Hospital of Aarhus, Skejby Sygehus, DK-8200 Aarhus N, Denmark.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1093/infdis/174.3.557